Search

everythinglearnresearchcommunity

for

Search:↓

The minoxidil-finasteride combination is more effective for hair growth than minoxidil alone.

PRP shows promise in healing and regeneration but needs standardized protocols for consistent results.

Skin changes can reveal serious hormone-related diseases, helping save lives.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The buffy coat method slightly outperformed apheresis in patient-reported hair improvement for treating hair loss.

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Intralesional corticosteroids are best for mild alopecia areata, and DPCP is best for severe cases.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

The InCISE score is a promising tool for assessing wound healing in head and neck surgery but needs more research for broader use.

Glioma treatment may improve with new therapies and technologies.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

The revised Chinese Symptom Checklist-90 is more reliable and valid for psychological assessments.

Treating cystoid macular oedema in uveitis is difficult and risky.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Women generally want more hair volume, which becomes a concern around menopause due to hair loss.

Nailfold dermoscopy is a simple, cheap way to check blood vessel changes in COVID-19 patients.

Girls with Autism Spectrum Disorder may show different symptoms than boys, leading to missed or delayed diagnoses.

PRP therapy can be effective for early-stage common hair loss, with most patients seeing improvement, but there are inconsistencies in treatment methods.

The document concludes that while lab results for hair growth promotion are promising, human trials are needed and better testing methods should be developed.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.